Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 5
2005 6
2006 4
2007 5
2008 7
2009 10
2010 9
2011 16
2012 12
2013 15
2014 19
2015 15
2016 14
2017 12
2018 19
2019 17
2020 24
2021 25
2022 20
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot study.
Sliwinski S, Faqar-Uz-Zaman SF, Heil J, Mohr L, Detemble C, Dreilich J, Zmuc D, Bechstein WO, Becker S, Chun F, Derwich W, Schreiner W, Solbach C, Fleckenstein J, Filmann N, Schnitzbauer AA. Sliwinski S, et al. Among authors: becker s. Patient Saf Surg. 2024 Apr 12;18(1):13. doi: 10.1186/s13037-024-00395-y. Patient Saf Surg. 2024. PMID: 38610002 Free PMC article.
Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?
Klimek L, Förster-Ruhrmann U, Olze H, Beule AG, Chaker AM, Hagemann J, Huppertz T, Hoffmann TK, Dazert S, Deitmer T, Strieth S, Wrede H, Schlenter WW, Welkoborsky HJ, Wollenberg B, Becker S, Bärhold F, Klimek F, Casper I, Zuberbier J, Rudack C, Cuevas M, Hintschich CA, Guntinas-Lichius O, Stöver T, Bergmann C, Werminghaus P, Pfaar O, Gosepath J, Gröger M, Beutner C, Laudien M, Weber RK, Hildebrand T, Hoffmann AS, Bachert C. Klimek L, et al. Among authors: becker s. Allergol Select. 2024 Mar 21;8:26-39. doi: 10.5414/ALX02460E. eCollection 2024. Allergol Select. 2024. PMID: 38549814 Free PMC article. Review.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gass P, Thiel FC, Häberle L, Ackermann S, Theuser AK, Hummel N, Boehm S, Kimmig R, Reinthaller A, Becker S, Hilpert F, Janni W, Vergote I, Harter P, Emons J, Hein A, Beckmann MW, Fasching PA, Pöschke P; AGO Uterus Commission. Gass P, et al. Among authors: becker s. Gynecol Oncol. 2024 Mar 14;183:25-32. doi: 10.1016/j.ygyno.2024.03.002. Online ahead of print. Gynecol Oncol. 2024. PMID: 38490057 Free article.
Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors.
Gasimli K, Raab M, Mandal R, Krämer A, Peña-Llopis S, Tahmasbi Rad M, Becker S, Strebhardt K, Sanhaji M. Gasimli K, et al. Among authors: becker s. Cancers (Basel). 2023 Dec 24;16(1):107. doi: 10.3390/cancers16010107. Cancers (Basel). 2023. PMID: 38201534 Free PMC article.
256 results